Related Experiment Videos
Smoking cessation improves insulin sensitivity in healthy middle-aged men
B Eliasson1, S Attvall, M R Taskinen
1Lundberg Laboratory for Diabetes Research, Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
European Journal of Clinical Investigation
|May 1, 1997
Summary
Smoking cessation improves insulin sensitivity and metabolic health in smokers, even with a slight weight gain. Quitting smoking helps reverse insulin resistance syndrome (IRS) markers.
Area of Science:
- Metabolic Health
- Endocrinology
- Cardiovascular Health
Background:
- Cigarette smoking is linked to insulin resistance, dyslipidemia, and insulin resistance syndrome (IRS).
- Understanding the metabolic impact of smoking cessation is crucial for public health.
- Previous research indicates a connection between smoking and adverse metabolic profiles.
Purpose of the Study:
- To investigate the effects of smoking cessation on insulin sensitivity.
- To evaluate the impact of quitting smoking on markers of the insulin resistance syndrome (IRS).
Main Methods:
- An open parallel study involving 40 male, non-obese healthy smokers.
- Participants were divided into a cessation group (17) and a control group (23).
- Insulin sensitivity was measured using the euglycaemic hyperinsulinaemic clamp technique; anthropometric and metabolic data were collected.
Main Results:
- Smoking cessation led to increased insulin sensitivity.
- The cessation group showed improved lipoprotein profiles despite a modest increase in body weight.
- Initial smoking habits correlated with BMI changes and metabolic improvements post-cessation.
Conclusions:
- Smoking cessation positively impacts insulin sensitivity and metabolic health.
- The metabolic benefits of quitting smoking outweigh the effects of minor weight gain.
- These findings support smoking as a cause of insulin resistance and IRS.